On July 7, 2023, Ingalls & Snyder, LLC announced that along with other shareholders are collectively proposing a change to the members of ImmunoPrecise Antibodies Ltd.âs board of directors. Ingalls & Snyder stated that the views of the informal group would be expressed through written and oral communications and might result in a call for a shareholder meeting on the issue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +10.55% | +4.76% | -22.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.81% | 34.74M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- IPA Stock
- News ImmunoPrecise Antibodies Ltd.
- Ingalls & Snyder Proposes a Change to the Members of ImmunoPrecise Antibodies’ Board